1. Home
  2. Analysis
  3. Dulcolax
  4. Evista

Dulcolax and Evista drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dulcolax (bisacodyl) and Evista (raloxifene hydrochloride). Common drug interactions include death among females and nephropathy among males.

The phase IV clinical study analyzes what interactions people have when they take Dulcolax and Evista. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Dulcolax?

Dulcolax has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 12,897 Dulcolax users. Check the latest studies of Dulcolax.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.

On Aug, 06, 2026

15 people who take Dulcolax and Evista together, and have interactions are studied.

Dulcolax and Evista drug interactions.

What are the common drug interactions of Dulcolax and Evista, by gender? *:

female:

  1. Death
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Rash
  4. Red cell distribution width increased
  5. Sinusitis (inflammation of sinus)
  6. Anaemia (lack of blood)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Cardiac failure congestive
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Diarrhoea

male:

  1. Nephropathy (damage to or disease of a kidney)

What are the common drug interactions of Dulcolax and Evista, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Nephropathy (damage to or disease of a kidney)

40-49:

n/a

50-59:

  1. Sedation

60+:

  1. Blood bilirubin decreased
  2. Blood chloride decreased
  3. Red cell distribution width increased
  4. Sinusitis (inflammation of sinus)
  5. Anaemia (lack of blood)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Cardiac failure congestive
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Death
  10. Diarrhoea

What are the existing conditions these people have? *

  1. Pain: 3 people, 20.00%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 20.00%
  3. Type 2 Diabetes: 2 people, 13.33%
  4. Back Pain: 2 people, 13.33%
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 13.33%
  6. Muscle Spasms (muscle contraction): 2 people, 13.33%
  7. High Blood Pressure: 2 people, 13.33%
  8. High Blood Cholesterol: 1 person, 6.67%
  9. Blood Glucose Increased: 1 person, 6.67%
  10. Blood Magnesium Decreased: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Dulcolax and Evista?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dulcolax and Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dulcolax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dulcolax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Evista and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bisacodyl and raloxifene hydrochloride (the active ingredients of Dulcolax and Evista, respectively), and Dulcolax and Evista (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.